Research ArticleCARDIOVASCULAR
RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis
Christophe Junot, Marie-Francoise Gonzales, Eric Ezan, Joel Cotton, Gilles Vazeux, Annie Michaud, Michel Azizi, Stamatia Vassiliou, Athanasios Yiotakis, Pierre Corvol and Vincent Dive
Journal of Pharmacology and Experimental Therapeutics May 2001, 297 (2) 606-611;
Christophe Junot
Marie-Francoise Gonzales
Eric Ezan
Joel Cotton
Gilles Vazeux
Annie Michaud
Michel Azizi
Stamatia Vassiliou
Athanasios Yiotakis
Pierre Corvol
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 297, Issue 2
1 May 2001
Research ArticleCARDIOVASCULAR
RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis
Christophe Junot, Marie-Francoise Gonzales, Eric Ezan, Joel Cotton, Gilles Vazeux, Annie Michaud, Michel Azizi, Stamatia Vassiliou, Athanasios Yiotakis, Pierre Corvol and Vincent Dive
Journal of Pharmacology and Experimental Therapeutics May 1, 2001, 297 (2) 606-611;
Research ArticleCARDIOVASCULAR
RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis
Christophe Junot, Marie-Francoise Gonzales, Eric Ezan, Joel Cotton, Gilles Vazeux, Annie Michaud, Michel Azizi, Stamatia Vassiliou, Athanasios Yiotakis, Pierre Corvol and Vincent Dive
Journal of Pharmacology and Experimental Therapeutics May 1, 2001, 297 (2) 606-611;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement